Theranautilus Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Theranautilus General Information
Description
Developer of micromanipulation tools designed for fabricating and controlling nanorobots for medical applications. The company's tools include instruments for the safe deployment and remote maneuvering of these nanorobots within living systems, enabling healthcare businesses by offering exact treatment options with reduced side effects.
Contact Information
Website
www.theranautilus.comCorporate Office
- Number 61, G Block, Manasa Prakrithi Building
- Sahakara Nagar Main Road
- Bangalore, Karnataka 560012
- India
Corporate Office
- Number 61, G Block, Manasa Prakrithi Building
- Sahakara Nagar Main Road
- Bangalore, Karnataka 560012
- India
Theranautilus Timeline
Theranautilus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 31-Jul-2026 | Completed | Generating Revenue | |||
| 7. Seed Round | 18-Nov-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 03-Jan-2023 | Completed | Startup | |||
| 5. Accelerator/Incubator | Completed | Startup | ||||
| 4. Accelerator/Incubator | Completed | Startup | ||||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Theranautilus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| CCPS | ||||||||
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Theranautilus Patents
Theranautilus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4773909-A1 | An enclosure adapted for placement on a tooth | Pending | 27-Nov-2023 | ||
| WO-2025115033-A1 | An enclosure adapted for placement on a tooth | Inactive | 27-Nov-2023 | ||
| AU-2023255525-A1 | Nanostructure, nanocomposite, and implementations thereof | Pending | 20-Apr-2022 | ||
| EP-4511343-A1 | Nanostructure, nanocomposite, and implementations thereof | Pending | 20-Apr-2022 | ||
| EP-4511343-A4 | Nanostructure, nanocomposite, and implementations thereof | Pending | 20-Apr-2022 | C01B33/24 |
Theranautilus Signals
Theranautilus Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Stargazer AIF | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Golden Sparrow | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Pi Ventures | Venture Capital | Minority |
Theranautilus FAQs
-
When was Theranautilus founded?
Theranautilus was founded in 2020.
-
Where is Theranautilus headquartered?
Theranautilus is headquartered in Bangalore, India.
-
What is the size of Theranautilus?
Theranautilus has 7 total employees.
-
What industry is Theranautilus in?
Theranautilus’s primary industry is Other Devices and Supplies.
-
Is Theranautilus a private or public company?
Theranautilus is a Private company.
-
What is Theranautilus’s current revenue?
The current revenue for Theranautilus is .
-
How much funding has Theranautilus raised over time?
Theranautilus has raised $1.25M.
-
Who are Theranautilus’s investors?
Stargazer AIF, , Golden Sparrow, , and Pi Ventures are 5 of 11 investors who have invested in Theranautilus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process